Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.52p
   
  • Change Today:
    -0.080p
  • 52 Week High: 2.95
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 2,054,390
  • Market Cap: £1.95m
  • RiskGrade: 435

Valirx Overview

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Registrars: Capita Registrars

Key Personnel

CFO: Gerald Desler
Chief Executive Officer : Mark Eccleston
Executive Director: Tralau Stewart
Non-Executive Chairman: Martin Gouldstone
Non-Executive Dir: Cathy Tralau-Stewart

Contact Details

Address: Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD
Website: http://www.valirx.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BLH13C52

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.52p
Change Today -0.080p
% Change -13.33 %
52 Week High 2.95
52 Week Low 0.42
Volume 2,054,390
Shares Issued 374.35m
Market Cap £1.95m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.04% above the market average35.04% above the market average35.04% above the market average35.04% above the market average35.04% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Price Trend
86.9% below the market average86.9% below the market average86.9% below the market average86.9% below the market average86.9% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Income Not Available
Growth
24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Valirx Dividends

No dividends found

Trades for 07-Jul-2025

Time Volume / Share Price
10:48 25,000 @ 0.59p
10:26 130,718 @ 0.53p
09:19 9,243 @ 0.60p
09:15 24,191 @ 0.59p
09:12 400,000 @ 0.52p

Valirx Key Personnel

CFO Gerald Desler

Top of Page